Author: JohnValbyNation

Crispr Therapeutics Plans Its First Clinical Trial for Genetic Disease

In late 2012, French microbiologist Emmanuelle Charpentier approached a handful of American scientists about starting a company, a Crispr company. They included UC Berkeley’s Jennifer Doudna, George Church at Harvard University, and his former postdoc Feng Zhang of the Broad Institute—the brightest stars in the then-tiny field of Crispr research. Back then barely 100 papers…

By JohnValbyNation March 20, 2019 0